Cargando…

Comparison of IL-33 and IL-5 family mediated activation of human eosinophils

Eosinophils are the prominent inflammatory cell involved in allergic asthma, atopic dermatitis, eosinophilic esophagitis, and hypereosinophilic syndrome and are found in high numbers in local tissue and/or circulating blood of affected patients. There is recent interest in a family of alarmins, incl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angulo, Evelyn L., McKernan, Elizabeth M., Fichtinger, Paul S., Mathur, Sameer K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6730854/ https://www.ncbi.nlm.nih.gov/pubmed/31490928 http://dx.doi.org/10.1371/journal.pone.0217807

Ejemplares similares

Eosinophils, beyond IL-5
por: Esnault, Stephane, et al.
Publicado: (2021)

Human differentiated eosinophils release IL-13 in response to IL-33 stimulation
por: Uchida, Amiko M., et al.
Publicado: (2022)

IL-25 and IL-33 Contribute to Development of Eosinophilic Airway Inflammation in Epicutaneously Antigen-Sensitized Mice
por: Morita, Hideaki, et al.
Publicado: (2015)

A role for IL-33–activated ILC2s in eosinophilic vasculitis
por: Kotas, Maya E., et al.
Publicado: (2021)

IL-33 reduces tumor growth in models of colorectal cancer with the help of eosinophils
por: Kienzl, Melanie, et al.
Publicado: (2020)

IL-33 Enhanced the Proliferation and Constitutive Production of IL-13 and IL-5 by Fibrocytes
por: Hayashi, Hisako, et al.
Publicado: (2014)

Activation of Eosinophils Interacting with Dermal Fibroblasts by Pruritogenic Cytokine IL-31 and Alarmin IL-33: Implications in Atopic Dermatitis
por: Wong, Chun-Kwok, et al.
Publicado: (2012)

Myeloid-IL4Rα is an indispensable link in IL-33-ILCs-IL-13-IL4Rα axis of eosinophil recruitment in murine lungs
por: Patial, Sonika, et al.
Publicado: (2021)

Tissue eosinophils express the IL‐33 receptor ST2 and type 2 cytokines in patients with eosinophilic esophagitis
por: Uchida, Amiko M, et al.
Publicado: (2021)

IL-33/IL-31 Axis in Immune-Mediated and Allergic Diseases
por: Murdaca, Giuseppe, et al.
Publicado: (2019)

The IL-33/IL-31 Axis in Allergic and Immune-Mediated Diseases
por: Murdaca, Giuseppe, et al.
Publicado: (2023)

A late IL-33 response after exposure to Schistosoma haematobium antigen is associated with an up-regulation of IL-13 in human eosinophils
por: Wilson, S, et al.
Publicado: (2013)

The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD
por: Tworek, Damian, et al.
Publicado: (2018)

IL-33 is induced in undifferentiated, non-dividing esophageal epithelial cells in eosinophilic esophagitis
por: Travers, J., et al.
Publicado: (2017)

12/15-Lipoxygenase Regulates IL-33-Induced Eosinophilic Airway Inflammation in Mice
por: Miyata, Jun, et al.
Publicado: (2021)

IL-33/IL-31 Axis in Osteoporosis
por: De Martinis, Massimo, et al.
Publicado: (2020)

Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory Diseases
por: Pitlick, Mitchell M., et al.
Publicado: (2022)

Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor
Publicado: (1988)

A complicated liaison: IL-33 and IL-33R in arthritis pathogenesis
por: Kamradt, Thomas, et al.
Publicado: (2013)

IL-33-Induced Cytokine Secretion and Survival of Mouse Eosinophils Is Promoted by Autocrine GM-CSF
por: Willebrand, Ralf, et al.
Publicado: (2016)

IL-5 and IL-6 are increased in the frontal recess of eosinophilic chronic rhinosinusitis patients
por: Kubota, Kazunori, et al.
Publicado: (2017)

Targeting the IL-5 pathway in eosinophilic asthma: a comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts
por: Ghassemian, Arian, et al.
Publicado: (2021)

Mouse resident lung eosinophils are dependent on IL‐5
por: Dolitzky, Avishay, et al.
Publicado: (2022)

IL-33 Mediates Lung Inflammation by the IL-6-Type Cytokine Oncostatin M
por: Botelho, Fernando, et al.
Publicado: (2020)

Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma
por: Drick, Nora, et al.
Publicado: (2020)

Treatment with interleukin (IL)-5/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD
por: Drick, Nora, et al.
Publicado: (2022)

IL-3 and TNFα increase Thymic Stromal Lymphopoietin Receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation
por: Cook, Ellen B, et al.
Publicado: (2012)

IL-33 promotes IL-10 production in macrophages: a role for IL-33 in macrophage foam cell formation
por: Zhang, Hai-Feng, et al.
Publicado: (2017)

Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma
por: Farahani, Rahim, et al.
Publicado: (2014)

Emerging roles for IL-25 and IL-33 in colorectal cancer tumorigenesis
por: Jou, Eric, et al.
Publicado: (2022)

Autophagy Protects against Eosinophil Cytolysis and Release of DNA
por: Esnault, Stephane, et al.
Publicado: (2022)

IL-33 and Airway Inflammation
por: Oboki, Keisuke, et al.
Publicado: (2011)

IL-33 in Mental Disorders
por: Pandolfo, Gianluca, et al.
Publicado: (2021)

IL-33 in Rheumatic Diseases
por: Dong, Yuanji, et al.
Publicado: (2021)

IL-33, IL-37, and Vitamin D Interaction Mediate Immunomodulation of Inflammation in Degenerating Cartilage †
por: Rai, Vikrant, et al.
Publicado: (2021)

Susceptibility to L. sigmodontis infection is highest in animals lacking IL-4R/IL-5 compared to single knockouts of IL-4R, IL-5 or eosinophils
por: Frohberger, Stefan J., et al.
Publicado: (2019)

Longitudinal changes in the expression of IL-33 and IL-33 regulated genes in relapsing remitting MS
por: Sriram, Subramaniam, et al.
Publicado: (2018)

Evidence for eosinophil and IL-17 mediated inflammation in allergic rhinitis
por: Amin, Kawa, et al.
Publicado: (2020)

Counteractive Effects of IL-33 and IL-37 on Inflammation in Osteoarthritis †
por: Rai, Vikrant, et al.
Publicado: (2022)

IL-33 reduces the development of atherosclerosis
por: Miller, Ashley M., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_u8tbcnapofse49hefdv63f9g5a